Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Jaguar Health (JAGX) Cash from Investing Activities (2016 - 2024)

Historic Cash from Investing Activities for Jaguar Health (JAGX) over the last 8 years, with Q4 2024 value amounting to -$215000.0.

  • Jaguar Health's Cash from Investing Activities changed N/A to -$215000.0 in Q4 2024 from the same period last year, while for Dec 2024 it was -$215000.0, marking a year-over-year change of. This contributed to the annual value of -$231000.0 for FY2024, which is N/A changed from last year.
  • Latest data reveals that Jaguar Health reported Cash from Investing Activities of -$215000.0 as of Q4 2024.
  • Over the past 5 years, Jaguar Health's Cash from Investing Activities peaked at $10.5 million during Q4 2021, and registered a low of -$10.5 million during Q3 2021.
  • Over the past 4 years, Jaguar Health's median Cash from Investing Activities value was -$135500.0 (recorded in 2022), while the average stood at -$106500.0.
  • Within the past 5 years, the most significant YoY rise in Jaguar Health's Cash from Investing Activities was 9946.55% (2022), while the steepest drop was 10344.53% (2022).
  • Jaguar Health's Cash from Investing Activities (Quarter) stood at -$7000.0 in 2020, then skyrocketed by 149785.71% to $10.5 million in 2021, then tumbled by 103.45% to -$361000.0 in 2022, then skyrocketed by 40.44% to -$215000.0 in 2024.
  • Its last three reported values are -$215000.0 in Q4 2024, -$361000.0 for Q4 2022, and -$56000.0 during Q3 2022.